Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Salaries and benefits

Supplies

Other operating expenses

Equity in earnings of affiliates

Depreciation and amortization

Interest expense

Gains on sales of facilities

Losses on retirement of debt

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

HCA Healthcare

HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

HCA Healthcare reports robust Q4 performance and outlines strategic growth

HCA Healthcare's Q4 2022 performance reflects strong same-facility volumes, stable labor costs, and strategic investments in growth areas.
The company's focus on overcoming challenges, leveraging strengths, and seizing opportunities positions them for sustainable growth and operational excellence.
With a clear agenda for 2023, including revenue guidance and investment plans, HCA Healthcare aims to navigate market dynamics and drive value creation.
By addressing key performance metrics, managing costs effectively, and pursuing strategic initiatives, HCA Healthcare demonstrates a commitment to long-term success.

HCA Healthcare reports robust Q1 earnings amidst operational enhancements

HCA Healthcare delivered strong financial performance with notable growth in key metrics and operational efficiency improvements.
While facing challenges from COVID-related impacts and procedural shifts, the company is focused on maintaining positive volume trends and managing costs effectively.
Opportunities lie in investing in capabilities, capacity improvement, and navigating contract renewals in an inflationary environment.

HCA Healthcare reports robust Q2 earnings amidst strategic investments

HCA Healthcare's Q2 2023 performance reflects strong earnings, revenue growth, and cash flow, supported by strategic investments.
While facing challenges like margin impact from acquisitions and rising capital spending, the company is well-positioned for growth.
Opportunities lie in optimizing labor costs, expanding services, and leveraging positive payer mix trends for sustained success.
Overall, HCA's focus on quality care, financial prudence, and growth initiatives underpins a positive outlook for the future.

HCA Healthcare manages challenges, eyes sustained growth amid revenue optimizations

HCA Healthcare navigated challenges from the Valesco venture to deliver solid financial performance. The company's focus on quality care, cost management, and revenue optimization positions it for sustained growth. Anticipation of improved margins, strategic growth discussions, and operational enhancements highlight a positive outlook for the future.

HCA Healthcare reports robust Q4 earnings and outlines growth strategies

HCA Healthcare's strong Q4 performance and strategic investments position it well for growth in 2024, with a focus on cost management and operational efficiency.
The company's confidence in navigating industry challenges, coupled with initiatives to drive value and improve patient outcomes, underpin its optimistic outlook for the future.
With a clear focus on growth drivers like Medicare Advantage admissions and revenue per equivalent admission, HCA Healthcare is poised for a promising year ahead.

HCA Healthcare posts robust Q1 earnings, eyes sustained growth opportunities

HCA Healthcare's Q1 2024 performance reflects strong financial results and operational efficiency, supported by favorable same-facility volumes and effective cost management. While facing challenges in outpatient cases, the company is well-positioned to capitalize on opportunities for growth.
Strategic investments in infrastructure, technology, and campus integration are strengthening HCA Healthcare's operational capabilities and market positioning. Monitoring Medicaid statuses and potential procedure rebounds are key focus areas for the company.

HCA Healthcare reports robust Q2 earnings amidst market challenges

HCA Healthcare's Q2 2024 performance reflects strong financial growth, driven by increased revenues and improved margins.
While challenges like managing capital expenditures persist, opportunities in payer mix optimization and market demand offer avenues for further growth.
The company's ability to navigate evolving market dynamics and capitalize on strategic opportunities will be key to sustaining its positive momentum.

HCA Healthcare reports resilient Q3 results amid hurricane challenges

HCA Healthcare's Q3 performance showcased resilience amidst hurricane challenges, with strong volume and revenue growth.
Investments in network expansion and technology underscore the company's commitment to quality care and operational efficiency.
While challenges from hurricanes persist, HCA Healthcare sees opportunities for earnings growth and value creation in the near future.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) will host its Investor Day today beginning at 8:00 a.m. CT. A team of HCA Healthcare leaders will offer perspectives on the Company's financial performance, operations, and strategy to drive growth and create value. Long-term Targets and Early Perspective on 2024 As part of Investor Day, the Company will discuss its strategic assessment of market opportunities and capital capacity. Based on this assessment, and subject to certai.

HCA Healthcare Provides Business Outlook Ahead of Investor Day

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conference: November 14, 2023 at 11:45am EST at the 2023 Wolfe Healthcare Conference held at Wolfe NYC Offices, New York, NY. A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be subject to change, plea.

HCA Healthcare to Present at November Healthcare Conference

Apollo Global Management

Aptiv Holdings Ltd

Capri Holdings Ltd

Zillow

In 2011, about 170 companies had an initial public offering (IPO) in the United States.

5 Best IPOs of 2011

Amplify Travel Tech ETF

Granite Construction

Invesco Dynamic Building & Construction ETF

Wingstop

Health Care Select Sector SPDR Fund

The U.S. economy added 150,000 jobs in October 2023, below market forecasts of 180,000.

3 Sector ETFs & Stocks to Gain Despite Soft Jobs Data

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it will gift $620,000 to the University of California, Riverside (UCR) to support five scholarships for students enrolled in the UCR School of Medicine. This gift is part of the Company's larger commitment to give $10 million over three years to Historically Black Colleges and Universities (HBCUs) and Hispanic Serving Institutions (HSIs). HCA Healthcare has.

HCA Healthcare Announces Grant to University of California, Riverside

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced the Company will host its 2023 Investor Day with analysts and institutional investors on Thursday, November 9, 2023, beginning at 8:00 a.m. CT. A team of HCA Healthcare leaders will offer perspectives on the Company's financial performance, operations, and strategies to drive growth and create value. In conjunction with Investor Day, the Company plans to provide early perspectives on the outlook for 2024 and long.

HCA Healthcare to Host 2023 Investor Day

HCA Healthcare, Inc. (NYSE:HCA ) Q3 2023 Earnings Conference Call October 24, 2023 10:00 AM ET Company Participants Sam Hazen - Chief Executive Officer Bill Rutherford - Chief Financial Officer Frank Morgan - Vice President of Investor Relations Conference Call Participants Kevin Fischbeck - Bank of America A.J. Rice - UBS Ben Hendrix - RBC Capital Markets Gary Taylor - T.D.

HCA Healthcare, Inc. (HCA) Q3 2023 Earnings Call Transcript

HCA Healthcare's (HCA) Q3 results were hurt by an increase in salaries and benefits expenses. Management presently estimates 2023 EPS to be within $17.80-$18.50, compared with the prior-view of $17.70-$18.90 per share.

HCA Healthcare's (HCA) Q3 Earnings Miss on High Expense Level

HCA beat on revenue but missed earnings estimates with its third-quarter report. Management credited strong demand for its top-line performance but noted its Valesco physician staffing joint venture performed below expectations.

Why HCA Healthcare Stock Dropped Today

While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HCA (HCA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

HCA Healthcare (HCA) came out with quarterly earnings of $3.91 per share, missing the Zacks Consensus Estimate of $3.97 per share. This compares to earnings of $3.93 per share a year ago.

HCA Healthcare (HCA) Lags Q3 Earnings Estimates

NASHVILLE, Tenn.--(BUSINESS WIRE)--The final table in this release has been corrected. The updated release reads: HCA HEALTHCARE REPORTS THIRD QUARTER 2023 RESULTS Revises 2023 Guidance HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2023. Key third quarter metrics (all percentage changes compare 3Q 2023 to 3Q 2022 unless otherwise noted): Revenues totaled $16.213 billion Net income attributable to HCA Healthcare, Inc. t.

CORRECTING and REPLACING HCA Healthcare Reports Third Quarter 2023 Results

Shares of HCA Healthcare HCA, -0.08% fell 9% premarket Tuesday, after the hospital operator reported third quarter profit that missed analysts' expectations. Net income was $1.079 billion, or $3.91 per share, compared with $1.134 billion, or $3.91 per share, a year earlier.

HCA Healthcare shares drop as third quarter profit falls below expectations

HCA Healthcare missed Wall Street estimates for quarterly profit on Tuesday, hurt by an increase in staffing costs as the company was impacted by its physician staffing joint venture Valesco.

HCA misses quarterly profit estimates on higher staffing cost

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2023. Key third quarter metrics (all percentage changes compare 3Q 2023 to 3Q 2022 unless otherwise noted): Revenues totaled $16.213 billion Net income attributable to HCA Healthcare, Inc. totaled $1.079 billion, or $3.91 per diluted share Adjusted EBITDA totaled $2.880 billion Cash flows from operating activities totaled $2.479 billion Sa.

HCA Healthcare Reports Third Quarter 2023 Results

HCA Healthcare's (HCA) third-quarter results are likely to reflect an increased occupancy rate and a lower average length of stay.

Will Rising Costs Hurt HCA Healthcare's (HCA) Q3 Earnings?

NASHVILLE, Tenn., & MENLO PARK, Calif.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA), one of the nation's leading healthcare providers, Sarah Cannon Cancer Institute, part of HCA Healthcare, and GRAIL, LLC, a healthcare company with a mission of detecting cancer early when it can be cured, today announced a strategic collaboration to advance comprehensive cancer care through early detection. Starting today, GRAIL's Galleri® multi-cancer early detection (MCED) test will be available to pati.

HCA Healthcare and Grail Collaborate to Advance Comprehensive Cancer Care With Multi-Cancer Early Detection Screening

Netflix

HCA Healthcare's services are always in demand, and the company benefits from an economic moat. Netflix is trying to phase out cable, a project that is going well and will continue for a long time.

2 No-Brainer Stocks to Buy With $500 and Hold for 20 Years

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare's Johnston-Willis Hospital in Richmond, Virginia, is the first hospital in the United States to provide treatment in a new clinical trial for patients with brain metastases from lung cancer. This clinical trial, conducted by HCA Healthcare Research Institute and sponsored by Insightec, a global healthcare company pioneering the use of focused ultrasound technology, investigates the benefit of combining noninvasive focused ultrasound with systemi.

First U.S. Patients Undergo Innovative Brain Cancer Treatment in New Clinical Trial at HCA Healthcare's Johnston-Willis Hospital

HCA Healthcare's consistent growth trajectory, ample liquidity, superior profitability, and attractive valuation make it a favorable investment. The company's fundamentals have shown consistent growth, with revenue and NOPAT increasing annually. HCA's leading market position, economies of scale, and strong cash flow contribute to its profitability and industry leadership.

HCA Healthcare: Rx For Success

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction, which include the Frist Humanitarian Award, the HCA Healthcare Innovators Award and the HCA Healthcare Excellence in Nursing Award, celebrate the organization's positive impact on patients, colleagues and communities by recognizing extr.

HCA Healthcare Presents 2023 Awards of Distinction

NASHVILLE, Tenn. & ORANGE, Calif. & ATLANTA & BOSTON--(BUSINESS WIRE)--A large multi-state study by the Centers for Disease Control and Prevention, Harvard Pilgrim Health Care Institute, HCA Healthcare and the University of California, Irvine has found that a nasal antibiotic ointment, mupirocin, which is currently used daily for intensive care unit (ICU) patients in only one-third of U.S. hospitals, is highly effective at preventing Staphylococcus aureus infections in critically ill patients,.

Large Clinical Trial by the Centers for Disease Control and Prevention, Harvard Pilgrim Health Care Institute, HCA Healthcare and UCI Health Identifies Best Strategy to Prevent Life-Threatening Health Care-Associated ICU Infections

HCA Healthcare (HCA) closed at $243.36 in the latest trading session, marking a -0.25% move from the prior day.

HCA Healthcare (HCA) Stock Sinks As Market Gains: Here's Why

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Tuesday, October 24, 2023 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call wi.

HCA Healthcare, Inc. 3rd Quarter 2023 Earnings Conference Call

The healthcare sector is experiencing a post-pandemic recovery, driven by increased costs, nursing shortages, and a growing aging population. The aging population in the US is expected to double within the next 40 years, putting immense fiscal pressure on healthcare spending. Medicare Advantage (Part C) is projected to become the largest revenue source for healthcare providers by 2026, with membership growing at about 8% year-over-year.

News for HCA Healthcare Stock (HCA)